Child and learning disability psychopharmacology

Abstract

In January 1997, the British Association for Psychopharmacology convened a Round Table meeting to look at issues surrounding the prescription of psychotropic drugs to children or individuals with learning disabilities. This followed reports in the UK media about increasing rates of prescription to children with attention deficit hyperactivity disorder (ADHD) and children who are depressed as well as concerns regarding the prescription of psychotropic drugs to both children and adults with learning disabilities. The participants included both clinical and basic scientists, psychiatrists and psychologists, as well as regulators and representatives of the pharmaceutical industry and they were drawn from the UK, the United States, Canada, Holland, France and Germany. The brief was to consider the evidence in favour of prescribing for individuals with learning disabilities or children with obsessive-compulsive disorder, schizophrenia, depression or ADHD and the basis on which prescribing could take place in the absence of clinical trial evidence of efficacy drawn from the populations in question, where prescribing is effectively off label or outside the remit of a medicine's product licence or sometimes must take place in the face of data sheet disclaimers that it is contraindicated.

Get full access to this article

View all access options for this article.

References

Birmayer B. , Ryan N.D. , Williamson D.E. , Brent D.A. , Kaufman J. (1996) Childhood and adolescent depression: a review of the past 10 years. Part II. J Am Acad Child Adolesc Psychiat 35: 1575-1583

British Paediatric Association (1996) Licensing medicines for children. British Paediatric Association , London.

Emslie GJ , et al (1997) A double-blind, randomized placebo-controlled trial of fluoxetine in depressed children. Archs Gen Psychiat in press

Flament M.F. (1994) Recent findings in childhood onset obsessive-compulsive disorder. In Hollander E , Zohar J , Marazziti D , Olivier B (eds), Current insights in obsessive-compulsive disorder. John Wiley, Chichester , pp. 23-40

Gittelman Klein R (1987). Pharmacotherapy of childhood hyperactivity: an update. In Meltzer H (ed.), Psychopharmacology: the third generation of progress. Raven Press, New York, pp. 1215-1224

Kalachnik J.E. , Leventhal B.L. , James D.H. , Sovner R. , Kastner TA , Walsh K. , Weisblatt S.A. , Klitzke M.G. (1996) Guidelines on the use of psychotropic medication in mental retardation—revised edited version of guidelines first presented 15-16 June 1995 at the International Consensus Conference, Ohio State University, Columbus, Ohio. Nisonger Center: UAP.